A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Shibasaki, Toshiaki
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). [electronic resource] - Clinical and experimental nephrology Jun 2004 - 117-26 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
1342-1751
10.1007/s10157-004-0276-0 doi
Adult
Drug Resistance
Female
Glomerulonephritis, Membranous--drug therapy
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Nephrotic Syndrome--drug therapy
Patient Dropouts
Product Surveillance, Postmarketing
Proteinuria--drug therapy
Remission Induction
Ribonucleosides--administration & dosage
Steroids--administration & dosage
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). [electronic resource] - Clinical and experimental nephrology Jun 2004 - 117-26 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
1342-1751
10.1007/s10157-004-0276-0 doi
Adult
Drug Resistance
Female
Glomerulonephritis, Membranous--drug therapy
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Nephrotic Syndrome--drug therapy
Patient Dropouts
Product Surveillance, Postmarketing
Proteinuria--drug therapy
Remission Induction
Ribonucleosides--administration & dosage
Steroids--administration & dosage